Max Healthcare Stock Outlook: Motilal Oswal Sets INR 1,360 Target on Robust 2QFY26 Results

Overview

Motilal Oswal's research report highlights Max Healthcare's strong 2QFY26 performance, with revenue growth exceeding 20% year-on-year and EBITDA growth meeting expectations. The company's strategic bed additions and expansion plans are expected to sustain this momentum. Existing units showed significant patient volume-driven growth, while new units are scaling up well. Motilal Oswal maintains its FY26/FY27/FY28 estimates and reiterates a target price of INR 1,360 for the stock.